Home | Drugs Approvals and Trials

Drugs Approvals and Trials

Study to investigate whether ibuprofen can reverse the effects of emphysema

Temple University Hospital (TUH) is participating in a nationwide phase II clinical trial that is testing the possibility that ibuprofen can reverse ...

New Technologies Fuel Patient Participation and Data Collection in Research

By Duke Medicine News and Communications - DURHAM, N.C. – The changing dynamic of health studies driven by “big data” research projects ...

Vulnerable need pre-trial counselling, say experts

Counsellors need more support to ensure they feel able to give victims of sexual abuse pre-trial counselling, experts will say at an event at The University of Manchester on July 8. ... Full story

FDA approves Beleodaq to treat rare, aggressive form of non-Hodgkin lymphoma

The U.S. Food and Drug Administration today approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma (PTCL), a rare and fast-growing type of non-Hodgkin lymphoma (NHL). The action was taken under the agency’s accelerated approval program. ... Full story

Sickle cell drug passes early phase trial

(SACRAMENTO, Calif.) - A potentially groundbreaking investigational drug designed to treat the painful vaso-occlusive crises that are the hallmark of sickle cell disease has been found to be safe following a clinical trial at UC Davis. ... Full story

Super bananas – world first human trial

The world's first human trial of pro-vitamin A-enriched banana, expected to lift the health and well-being of millions of Ugandans and other East Africans will start very soon. ... Full story

New clinical trial rules boost patient benefit in Europe

The European Parliament has today (Thursday) approved a new set of rules governing clinical trials that will help our understanding of disease, improve treatments for patients and make Europe a more attractive place to conduct research and development. ... Full story

Time, trust and transparency keys to minority biospecimen collection

UC Davis leads study on strategies to even the clinical research playing field ... Full story

FDA approves Impavido to treat tropical disease leishmaniasis

The U.S. Food and Drug Administration today approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. ... Full story

Minority clinical trials participation and analysis still lag 20 years after federal mandate

UC Davis researchers urge renewed recruitment and research effort ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 491 | displaying: 1 - 10